Biofrontera Inc. (BFRI)
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.
$1.16-0.06%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+11.4%
The outlook
Biofrontera Inc. currently reads as bullish based on above its 50- & 200-day averages, 84% of the way from its 52-week low to high, avg target +407% vs current price. This is a snapshot of current market data, not a forecast.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range84% of the way from its 52-week low to high
Price targetAvg target +407% vs current price
Analyst price target
~12-month · 2 analysts$5.88average target+407.3% vs now
Now $1.16
Low $2.75High $9.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$14.8M
52-wk high
$1.27
52-wk low
$0.56
50-day avg
$1.00
200-day avg
$0.93
Trailing P/E
—